230 results
POS AM
EX-23.1
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1
POS AM
kyk7hepu8n
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
POS AM
EX-23.2
af61c kdxzh9lwbdkkw
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
424B3
3f989kt
18 Mar 24
Prospectus supplement
4:06pm
8-K
EX-10.1
dx39w1to
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
8-K
EX-10.2
i4nm6ae cpwgztdq
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
POS AM
u2cpqykdks5
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
EX-23.1
jdvr5
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
EX-23.2
amlehu
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
EX-23.2
vklf57r2zbtkbhf2meb
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
POS AM
4w6afxfopr
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
POS AM
EX-23.1
4jtc 1fmuh54a66irr
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm